At the beginning of 2016 the Budapest Group released Recommendations on EU Engagement at 2016 UN General Assembly Special Session (UNGASS) on Drugs
“The priority message of the Budapest Group is that civil society organizations must have a central role in the UNGASS deliberations, and that marginalized groups disproportionately impacted by drug policies, including women, youth, ethnic minorities and drug crop cultivators must be engaged in deliberations on, and the design, evaluation and monitoring of drug policies,” <br>explained SPP Associate Dean Julia Buxton.
The Budapest Group is a network of European NGOs working in the field of drug policy reform, including Harm Reduction International, the Global Drug Policy Program of the Open Society Foundations (OSF), the International Federation of Red Cross and Red Crescent Societies (IFRC), Transform Drug Policy Foundation, the International Drug Policy Consortium, the Hungarian Civil Liberties Union, and the Transnational Institute.
The text released from the Budapest Group is entitled: A call for EU leadership on drug policy: Principles and recommendations from EU civil societyfor EU engagement at the 2016 UNGASS on drugs.
In the document is stated: “Member states
should advocate for drug policy evaluation and metrics that relate directly to the key pillars of the UN: human development, peace and security, and human rights, and recommend strategies, metrics and approaches that are informed by the five thematic areas of the UNGASS.”